A new business intelligence report released by DBMR titled “ Europe Medical Cannabis Market Size , Share, Growth, Industry Trends and Forecast to Europe Medical Cannabis” is designed to cover the micro level of analysis by manufacturers and major business segments. The Global Medical Cannabis Market survey analysis offers energetic visions to conclude and study market size, market hopes, and competitive surroundings. This report also provides a superior market perspective in terms of product trends, marketing strategy, future products, new geographic markets, future events, sales strategies, customer actions or behaviors. The research is derived from primary and secondary statistical sources and includes qualitative and quantitative detail.
Europe Medical Cannabis Market report provides detailed analysis of global market size, regional and country level market size, segmentation market growth, market share, competitive landscape, analysis sales, impact of national and global market players, value chain optimization, trade. regulations, recent developments, opportunity analysis, strategic market growth analysis, product launches, regional market expansion and technological innovations.
Get Full Sample PDF Copy of Report: (Including Full Table of Contents, List of Tables and Figures, Chart)@ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=europe-medical-cannabis-market
Analysis and size of the global medical cannabis market in Europe
Medical Cannabis Market is expected to witness market growth during the forecast period from 2021 to 2028. Data Bridge Market Research analyzes that the market is growing at a CAGR of 24.5% during the forecast period from 2021 to 2028 and is expected to reach USD 19,153.13 million by 2028. Rising medical use and legalization of cannabis is acting as a driver for the medical cannabis market.
Key Players Mentioned in the Europe Medical Cannabis Market Research Report:
Tilray, Elixinol Europe Limited, Medical Marijuana, Inc., Peace Naturals Project Inc., BOL Pharma, PharmaHemp, Kiehl’s (subsidiary of L’ORÉAL), ENDOCA, CANOPY GROWTH CORPORATION, Aurora Cannabis, GW Pharmaceuticals plc, Althea Company Pty Ltd ( subsidiary of the Althea group)
This comprehensive report on the European Medical Cannabis Market helps to determine the gaps and issues faced by the dominant or new companies. It also provides information about the potential impact of the existing COVID-19 on the market scenario. Europe Medical Cannabis market is split by Type and by Application. For the period 2018-2027, the growth between segments provides accurate calculations and forecasts of sales by type and application in terms of volume and value. This analysis can help you grow your business by targeting qualified niche markets.
Segmentation of the medical cannabis market in Europe:
By Product (Oil, Dried Medical Cannabis, Medical Cannabis Capsules, Vape Pen, Whole Flower, Creams & Moisturizer, Ground Flower, Patch, Mask & Serum, Cleanser, Others), Source (Natural, Synthetic), Species (Sativa, Hybrid , Cannabis Indica), Derivatives (Cannabidiol (CBD), Tetrahydrocannabinol (THC)/Delta-8-Tetrahydrocannabinol, Cannabigerol (CBG), Cannabinol, Others), Application (Pain management, Anxiety, Muscle spasms, Nausea, Loss of appetite, Cancer, Arthritis, Alzheimer’s disease, epilepsy, depression and sleep disorders, multiple sclerosis, autism, mental health problems, mood enhancement, others), route of administration (oral solutions and capsules, smoking , topicals, vaporizers, others), end user (home care facilities, hospitals and rehabilitation centers, pharmaceutical industry, research and development centers, others), distribution channel (B2C,B2B)
Full report (full table of contents, tables and figures) @ https://www.databridgemarketresearch.com/toc/?dbmr=europe-medical-cannabis-market
+Geographic segment covered in the report:
The Europe Medical Cannabis report provides information on the market area, which is sub-divided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities. This chapter of the report mentions the market share and growth rate of each region, country and sub-region over the estimated period.
North America (USA and Canada)
• Europe (UK, Germany, France and rest of Europe)
• Asia-Pacific (China, Japan, India and rest of the Asia-Pacific region)
• Latin America (Brazil, Mexico and the rest of Latin America)
• Middle East and Africa (GCC and Rest of Middle East and Africa)
Scope of the medical cannabis market and market size
The medical cannabis market is categorized into eight notable segments based on product, source, species, derivatives, application, route of administration, end user, and distribution channel. Growth between segments helps you analyze growth niches and strategies to approach the market and determine your main application areas and the difference between your target markets.
On the basis of product, the medical cannabis market is segmented into oil, medical cannabis capsules, patch, whole flower, ground flower, vape pen, dried medical cannabis, creams & moisturizer, mask & serum, cleanser and others. In 2021, the oil segment is expected to dominate the medical cannabis market owing to the adoption of high technology by major market players.
On the basis of source, the medical cannabis market is segmented into synthetic and natural. In 2021, the synthetic segment is expected to dominate the medical cannabis market owing to the increase in healthcare expenditure.
On the basis of species, the medical cannabis market is segmented into indica, sativa and hybrid cannabis. In 2021, the cannabis indica segment is expected to dominate the medical cannabis market owing to the increase in the medical use of cannabis.
Based on derivatives, the medical cannabis market is segmented into cannabidiol (CBD), tetrahydrocannabinol (THC)/delta-8-tetrahydrocannabinol, cannabinol, cannabigerol (CBG) and others. In 2021, the cannabidiol (CBD) segment is expected to dominate the medical cannabis market owing to the growing demand for medical marijuana products in the market.
Based on application, the medical cannabis market is segmented into Alzheimer’s disease, loss of appetite, cancer, epilepsy, autism, mental health issues, multiple sclerosis, pain management, nausea, muscle spasms , arthritis, high mood, depression and sleep disorders, anxiety and others. In 2021, the Alzheimer’s disease segment is expected to dominate the medical cannabis market due to increasing R&D activities.
Based on route of administration, the medical cannabis market is segmented into oral solutions and capsules, cigarettes, vaporizers, topicals, and others. In 2021, the oral solutions and capsules segment is expected to dominate the medical cannabis market owing to the growing prevalence of chronic diseases.
On the basis of end-user, the medical cannabis market is segmented into pharmaceutical industry, research and development centers, home care facilities, hospitals and rehabilitation centers and others. In 2021, the pharmaceutical industry segment is expected to dominate the medical cannabis market owing to the increase in the geriatric population and the prevalence of chronic diseases.
Based on distribution channel, the medical cannabis market is segmented into B2B and B2C. In 2021, the B2B segment is expected to dominate the medical cannabis market owing to the growing demand for cannabis for medical and clinical purposes.
Read the detailed index of the full research study at https://www.databridgemarketresearch.com/reports/europe-medical-cannabis-market
Answers to key questions in this European medical cannabis market report
How much revenue will the European Medical Cannabis Market generate by the end of the forecast period?
Which market segment is expected to have the maximum market share?
What are the influencing factors and their impact on the European medical cannabis market?
Which regions are currently contributing the maximum share of the overall medical cannabis market in Europe?
Which indicators are likely to drive the European medical cannabis market?
What are the main strategies of the major players in the European medical cannabis market to expand their geographical presence?
What are the key advancements in the European medical cannabis market?
How do regulatory standards affect the European medical cannabis market?
Thank you for your interest in the Europe Medical Cannabis Market publication; you can also get an individual chapter or a regional or country report for USA, GCC, Southeast Asia, North America, Europe, APAC or LATAM.